Stock listing
BOATS:BRTX BioRestorative Therapies, Inc. Stock
US listing (BOATS) of BioRestorative Therapies, Inc. · home listing NASDAQ:BRTX
Follow BioRestorative Therapies, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:BRTX
$1.52 USD +0.01 (+0.7%)
Close on Nov 6, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:BRTX
- Day range
- $1.48 – $1.54 USDNov 6, 2026
- Volume
- 11,416 sharesNov 6, 2026
- Market cap
- $2.10M USDAt the close on Nov 6, 2026 · price × 1.38M shares outstanding
- 52-week range
- $0.142 – $2.93 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $45,281 USDMedian day 16,895 shares · 1 day with no trades · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BRTX · Home | $1.52 USD | +0.01 (+0.7%) | 11,416 | $1.503 | $1.54 | $1.48 | $1.51 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:BRTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.52 | +0.01 | +0.7% | $1.503 | $1.54 | $1.48 | 11,416 | |
| $1.51 | 0.00 | 0.0% | $1.57 | $1.62 | $1.499 | 17,493 | |
| $1.51 | +0.03 | +2.0% | $1.48 | $1.59 | $1.48 | 12,534 | |
| $1.48 | 0.00 | 0.0% | $1.50 | $1.53 | $1.43 | 26,256 | |
| $1.48 | +0.08 | +5.7% | $1.419 | $1.508 | $1.419 | 13,192 | |
| $1.40 | -0.18 | -11.4% | $1.55 | $1.55 | $1.40 | 28,629 | |
| $1.58 | +0.19 | +13.7% | $1.44 | $1.65 | $1.39 | 232,675 | |
| $1.39 | +0.03 | +2.2% | $1.39 | $1.47 | $1.38 | 17,259 | |
| $1.36 | -0.22 | -13.9% | $1.53 | $1.54 | $1.36 | 8,667 | |
| $1.58 | -0.04 | -2.5% | $1.58 | $1.58 | $1.45 | 34,749 | |
| $1.62 | +0.12 | +8.0% | $1.503 | $1.65 | $1.40 | 33,225 | |
| $1.50 | -0.03 | -2.0% | $1.57 | $1.62 | $1.50 | 4,808 | |
| $1.53 | -0.03 | -1.9% | $1.58 | $1.58 | $1.51 | 13,107 | |
| $1.56 | -0.04 | -2.5% | $1.618 | $1.65 | $1.54 | 16,515 | |
| $1.60 | +0.06 | +3.9% | $1.51 | $1.67 | $1.51 | 18,369 | |
| $1.54 | +0.08 | +5.5% | $1.53 | $1.55 | $1.49 | 21,012 | |
| $1.46 | -0.04 | -2.7% | $1.50 | $1.50 | $1.28 | 27,941 | |
| $1.50 | -0.09 | -5.7% | $1.50 | $1.56 | $1.42 | 18,428 | |
| $1.59 | -0.16 | -9.1% | $1.70 | $1.71 | $1.439 | 32,400 | |
| $1.75 | -0.16 | -8.4% | $1.85 | $1.90 | $1.705 | 11,400 | |
| $1.91 | +0.02 | +1.1% | $1.92 | $1.95 | $1.85 | 18,400 | |
| $1.89 | -0.35 | -15.6% | $2.18 | $2.18 | $1.75 | 95,600 | |
| $2.24 | -0.03 | -1.3% | $2.30 | $2.30 | $2.05 | 37,800 | |
| $2.27 | +0.03 | +1.3% | $2.20 | $2.29 | $2.135 | 79,700 | |
| $2.24 | +0.10 | +4.7% | $2.16 | $2.305 | $2.01 | 85,200 | |
| $2.14 | -0.13 | -5.7% | $2.26 | $2.432 | $2.14 | 25,500 | |
| $2.27 | -0.06 | -2.6% | $2.28 | $2.468 | $2.25 | 21,500 | |
| $2.33 | 0.00 | 0.0% | $2.26 | $2.39 | $2.26 | 24,900 | |
| $2.33 | +0.02 | +0.9% | $2.32 | $2.34 | $2.26 | 15,100 | |
| $2.31 | -0.24 | -9.4% | $2.42 | $2.49 | $2.29 | 49,400 | |
| $2.55 | +0.04 | +1.6% | $2.55 | $2.68 | $2.445 | 28,500 | |
| $2.51 | -0.09 | -3.5% | $2.59 | $2.69 | $2.51 | 24,300 | |
| $2.60 | +0.05 | +2.0% | $2.61 | $2.90 | $2.53 | 85,200 | |
| $2.55 | -0.16 | -5.9% | $2.72 | $2.929 | $2.50 | 67,000 | |
| $2.71 | +0.02 | +0.7% | $2.70 | $2.75 | $2.68 | 26,800 | |
| $2.69 | +0.035 | +1.3% | $2.71 | $2.79 | $2.67 | 17,400 | |
| $2.655 | +0.105 | +4.1% | $2.66 | $2.738 | $2.58 | 12,400 | |
| $2.55 | -0.09 | -3.4% | $2.62 | $2.67 | $2.55 | 15,500 | |
| $2.64 | -0.06 | -2.2% | $2.73 | $2.77 | $2.62 | 9,600 | |
| $2.70 | +0.03 | +1.1% | $2.68 | $2.735 | $2.658 | 7,100 | |
| $2.67 | -0.09 | -3.3% | $2.75 | $2.78 | $2.63 | 10,300 | |
| $2.76 | +0.02 | +0.7% | $2.82 | $2.82 | $2.701 | 27,400 | |
| $2.74 | +2.592 | +1751.4% | $2.72 | $2.905 | $2.61 | 48,900 | |
| $0.148 | 0.00 | 0.0% | $0.148 | $0.148 | $0.148 | 0 | |
| $0.148 | +0.004 | +2.8% | $0.148 | $0.15 | $0.144 | 38,215 | |
| $0.144 | -0.058 | -28.7% | $0.164 | $0.178 | $0.142 | 175,720 | |
| $0.202 | +0.004 | +2.0% | $0.204 | $0.21 | $0.20 | 24,465 | |
| $0.198 | -0.004 | -2.0% | $0.202 | $0.202 | $0.196 | 8,310 | |
| $0.202 | +0.002 | +1.0% | $0.20 | $0.206 | $0.20 | 10,675 | |
| $0.20 | -0.006 | -2.9% | $0.22 | $0.22 | $0.196 | 12,235 | |
| $0.206 | -0.01 | -4.6% | $0.226 | $0.226 | $0.198 | 16,530 | |
| $0.216 | -0.006 | -2.7% | $0.22 | $0.224 | $0.214 | 2,940 | |
| $0.222 | +0.008 | +3.7% | $0.23 | $0.23 | $0.214 | 5,130 | |
| $0.214 | -0.002 | -0.9% | $0.218 | $0.23 | $0.21 | 7,595 | |
| $0.216 | -0.004 | -1.8% | $0.224 | $0.224 | $0.214 | 3,790 | |
| $0.22 | +0.006 | +2.8% | $0.228 | $0.234 | $0.22 | 9,630 | |
| $0.214 | 0.00 | 0.0% | $0.22 | $0.228 | $0.214 | 9,220 | |
| $0.214 | -0.006 | -2.7% | $0.224 | $0.224 | $0.21 | 8,260 | |
| $0.22 | -0.006 | -2.7% | $0.23 | $0.234 | $0.22 | 11,220 | |
| $0.226 | +0.006 | +2.7% | $0.23 | $0.236 | $0.222 | 8,385 | |
| $0.22 | +0.008 | +3.8% | $0.216 | $0.236 | $0.216 | 15,870 | |
| $0.212 | +0.002 | +1.0% | $0.216 | $0.226 | $0.212 | 17,345 | |
| $0.21 | +0.008 | +4.0% | $0.206 | $0.22 | $0.206 | 15,635 | |
| $0.202 | -0.002 | -1.0% | $0.21 | $0.22 | $0.202 | 13,445 | |
| $0.204 | -0.004 | -1.9% | $0.22 | $0.22 | $0.204 | 16,000 | |
| $0.208 | -0.002 | -1.0% | $0.21 | $0.22 | $0.202 | 8,025 |
- Ticker
- BOATS:BRTX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Sep 2, 2026
BioRestorative Therapies Announces Reverse Stock Split
Latest earnings call · Nov 12, 2025
BioRestorative Therapies (NASDAQ:BRTX) Q3 2025 Earnings Call
Replay and transcript
Latest deck · Apr 23, 2026
Investor Presentation (April 2026)
Investor deck · 37 slides
Calls
Replays
BioRestorative Therapies (NASDAQ:BRTX) Q3 2025 Earnings Call
Wed, Nov 12, 2025 · 4:30 PM ET
Watch TranscriptBioRestorative Therapies (NASDAQ:BRTX) Q2 2025 Earnings Call
Tue, Aug 12, 2025 · 4:30 PM ET
Watch TranscriptBioRestorative Therapies (NASDAQ:BRTX) Q1 2025 Earnings Call
Wed, May 14, 2025 · 4:30 PM ET
Watch Transcript
Latest news
BioRestorative Therapies Announces Reverse Stock Split
Sep 2, 2026
Closed $0.144 (-28.7%) on Sep 3, 2026
BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform
Jun 25, 2026
Closed $0.394 (-1.0%) on Jun 25, 2026
BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth
Jun 18, 2026
Closed $0.41 (+2.5%) on Jun 18, 2026
Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX)
May 27, 2026
Closed $0.432 (+72.8%) on May 27, 2026
Issued by another party
BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data
May 26, 2026
Closed $0.25 (+20.2%) on May 26, 2026
BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals
May 13, 2026
Closed $0.186 (-6.1%) on May 13, 2026
BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease
May 7, 2026
Closed $0.226 (-7.4%) on May 7, 2026
BioRestorative Therapies to Present New Data at ISCT 2026 Highlighting Its Ongoing Phase 2 Clinical Trial in Chronic Lumbar Disease and Its BioCosmeceutical Platform
Apr 30, 2026
Closed $0.226 (+11.9%) on Apr 30, 2026
BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform
Apr 21, 2026
Closed $0.238 (-7.8%) on Apr 21, 2026
BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform
Apr 7, 2026
Closed $0.25 (-0.8%) on Apr 7, 2026
Financings
Public offering of shares of common stock (or pre-funded warrants) and accompanying warrants
Feb 14, 2026
Closed: US$5M raised · US$0.35 a share · Warrants at US$0.35 for 60 months · Rodman & Renshaw LLC
Dealers: Rodman & Renshaw LLC (lead)
Use of proceeds: BRTX-100 clinical trials, ThermoStem pre-clinical R&D, biocosmeceuticals platform development, general corporate purposes and working capital
Registered direct offering of common stock with concurrent unregistered warrants
Oct 6, 2025
Announced: US$1.08M · US$1.6 a share · Warrants at US$2.75 for 60 months · Alere Financial Partners (a division of Cova Capital Partners, LLC)
Dealers: Alere Financial Partners (a division of Cova Capital Partners, LLC) (lead)
Insiders: Members of the executive team participated
Use of proceeds: BRTX-100 clinical trials, ThermoStem pre-clinical R&D, biocosmeceuticals platform development, general corporate purposes and working capital
Decks
Investor Presentation (April 2026)
Investor deck · 37 slides · Apr 23, 2026
Investor Presentation (September 2025)
Investor deck · 27 slides · September 2025
Investor Presentation (August 2025)
Investor deck · 27 slides · Aug 14, 2025
Q1 2025 Earnings Presentation
Earnings · 27 slides · May 14, 2025
BioRestorative Therapies, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 21 in the last 12 months · 121 in all · newest Sep 2, 2026 · oldest 2019
- Calls
- 7 calls with a replay · 7 with a transcript · latest Nov 12, 2025
- Decks
- 38 decks · latest Apr 23, 2026
Where BioRestorative Therapies, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BRTX · Home listing | NASDAQ | United States | USD |
| LS Exchange:A3C9XF | LS Exchange | Germany | EUR |
| BOATS:BRTX · This page | BOATS | United States | USD |
| Lang & Schwarz:A3C9XF | Lang & Schwarz | Germany | EUR |
| gettex:9OF | gettex | Germany | EUR |
| Tradegate:9OF | Tradegate | Germany | EUR |
| Frankfurt:9OF | Frankfurt | Germany | EUR |
| Munich:9OF | Munich | Germany | EUR |
| Stuttgart:9OF | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about BioRestorative Therapies, Inc.